DNAGinkgo Bioworks Holdings, Inc.

NYSE ginkgobioworks.com


$ 6.69 $ -0.40 (-5.64 %)    

Friday, 30-Aug-2024 15:59:44 EDT
QQQ $ 476.00 $ 5.61 (1.19 %)
DIA $ 416.44 $ 2.30 (0.56 %)
SPY $ 563.62 $ 5.33 (0.95 %)
TLT $ 96.60 $ -1.04 (-1.07 %)
GLD $ 231.30 $ -1.66 (-0.71 %)
$ 6.69
$ 6.70 x 100
-- x --
-- - --
$ 6.64 - $ 98.60
1,451,808
na
371.8M
$ 2.58
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 02-29-2024 12-31-2023 10-K
4 11-08-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-10-2023 03-31-2023 10-Q
7 03-13-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-28-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 05-24-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 btig-maintains-sell-on-ginkgo-bioworks-holdings-adjusts-price-target-to-7-1-40-reverse-stock-split

BTIG analyst Mark Massaro maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell, adjusts target to $7 from $0.2 (1-40 Rever...

 ginkgo-bioworks-holdings-q2-2024-gaap-eps-011-misses-007-estimate-sales-5621m-beat-4314m-estimate

Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate ...

 goldman-sachs-maintains-sell-on-ginkgo-bioworks-holdings-lowers-price-target-to-03

Goldman Sachs analyst Matthew Sykes maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and lowers the price target fr...

 cathie-woods-ark-invest-acquires-73m-worth-of-shares-in-this-promising-netflix-competitor-sells-off-coinbase-stock-amid-bitcoin-slump

On Wednesday, Cathie Wood-led Ark Invest made significant trades in Roku Inc (NASDAQ:ROKU) and Coinbase Global Inc (NASDAQ:COIN...

 btig-maintains-sell-on-ginkgo-bioworks-holdings-lowers-price-target-to-02

BTIG analyst Mark Massaro maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and lowers the price target from $0.5 to...

 ginkgo-bioworks-says-on-june-17-it-began-implementing-previously-announced-restructuring-with-headcount-reductions-which-it-expects-to-result-in-total-reduction-of-at-least-35-of-workforce-when-all-impacted-employees-have-departed---filing

As previously announced, on May 9, 2024, in connection with the Company’s multi-year plan to reduce operational expenditures, m...

 cathie-woods-ark-innovation-etf-sees-sharp-decline-among-top-holdings--here-are-10-largest-losers-within-arkf

Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced b...

 investment-advisor-says-throwing-random-darts-at-tickers-would-beat-arkk-as-cathie-woods-flagship-fund-lags-far-behind-soaring-market-how-do-they-do-it

Ram Ahluwalia of Lumida Wealth pointed to Ark's flagship ETF trading over 70% below its all-time high amid the S&P 500&...

 btig-downgrades-ginkgo-bioworks-holdings-to-sell

BTIG analyst Mark Massaro downgrades Ginkgo Bioworks Holdings (NYSE:DNA) from Neutral to Sell.

 morgan-stanley-maintains-equal-weight-on-ginkgo-bioworks-holdings-lowers-price-target-to-1

Morgan Stanley analyst Tejas Savant maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Equal-Weight and lowers the price t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION